Psychemedics Profit Margin 2010-2024 | PMD
Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of June 30, 2024 is -21.5%.
| Psychemedics Annual Profit Margins |
|---|
| Psychemedics Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.014B | $0.022B |
| Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.223B | 12.84 |
| Quest Diagnostics (DGX) | United States | $17.268B | 17.71 |
| DaVita (DVA) | United States | $13.687B | 16.84 |
| Encompass Health (EHC) | United States | $9.264B | 22.79 |
| Chemed (CHE) | United States | $8.808B | 27.08 |
| Elanco Animal Health (ELAN) | United States | $7.449B | 16.74 |
| Option Care Health (OPCH) | United States | $5.396B | 26.51 |
| RadNet (RDNT) | United States | $5.150B | 122.18 |
| Amedisys (AMED) | United States | $3.183B | 22.77 |
| Astrana Health (ASTH) | United States | $2.839B | 40.17 |
| LifeStance Health (LFST) | United States | $2.625B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.408B | 29.24 |
| U.S Physical Therapy (USPH) | United States | $1.282B | 34.70 |
| Pennant (PNTG) | United States | $1.076B | 51.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.063B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.211B | 0.00 |
| Daxor (DXR) | United States | $0.044B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |